Radiation Recall Dermatitis After Capecitabine in a Patient With Triple Negative Breast Cancer

3Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A case is descibed of radiation recall dermatitis in a patient treated with adjuvant radiation therapy followed by capecitabine for triple negative breast cancer with residual disease after neoadjuvant chemotherapy.

Cite

CITATION STYLE

APA

Laird, J., Leventhal, J., Kanowitz, J., & Damast, S. (2021). Radiation Recall Dermatitis After Capecitabine in a Patient With Triple Negative Breast Cancer. Practical Radiation Oncology, 11(6), 448–452. https://doi.org/10.1016/j.prro.2021.06.001

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free